Category survey

Inflammation, Amyloid and Atrophy in The Aging Brain: The Borders between Healthy Brain Aging and Neurodegeneration Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Development of a Novel F18-PET tracer for early diagnosis of Alzheimers Dementia Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Public dementia care in terms of equal services – family, local and multiethnic perspectives Investments > €500k Norway Alzheimer’s disease & other dementias|Neurodegenerative disease in general 2016    

Mitochondrial dysfunction in the pathogenesis of Parkinsons disease: elucidating disease mechanisms and identifying therapeutic targets Investments > €500k Norway Parkinson’s disease & PD-related disorders 2016    

Protein kinase inhibitors for dementia Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

HOME-based ICT solutions FOR the independent living of people with DEMentia and their caregivers Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

The role of the blood-brain barrier in Alzheimers disease function Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Parkinson’s disease – from genetic risk factors to molecular mechanisms and clinical phenotypes Investments > €500k Norway Parkinson’s disease & PD-related disorders 2016    

Mitochondrial dysfunction in the pathogenesis of Parkinson’s disease: identifying novel disease mechanisms and designing treatments Investments > €500k Norway Parkinson’s disease & PD-related disorders 2016    

The Norwegian Cognitive impairment After STroke (COAST) study Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Identifying genetic risk of dementia: from gene discovery to clinical implications Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

New biomarkers for early detection of Alzheimer’s disease Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

MOLECULAR MECHANISMS IN DELIRIUM AND DEMENTIA: IDENTIFICATION OF POTENTIAL THERAPEUTIC TARGETS Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Towards Alzheimer’s disease pre-dementia intervention: Meeting-point of diagnostics, genetics, and individual risk estimates Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Regulatory mechanisms of dopamine synthesis; towards a therapeutic correction of catecholamine neurotransmiter deficiencies Investments > €500k Norway Parkinson’s disease & PD-related disorders 2016    

Transgenic mice with elevated basal level of calcium ions in neurons as a model of agedinduced neurodegeneration of sporadic Alzheimer’s disease Investments > €500k Poland Alzheimer’s disease & other dementias 2016    

Knowledge transfer in the field of redox biology for development of advanced molecular instruments in neurodegenerative diseases – the signature of transcription factor Nrf2 for diagnostic and treatment, REDBRAIN Investments > €500k Romania Alzheimer’s disease & other dementias|Neurodegenerative disease in…

Amyloid and vessels: Imaging the role of cerebrovascular function Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

Carriers Break Barriers in Drug Delivery Investments > €500k Netherlands Neurodegenerative disease in general 2016    

Developing smart glasses with light therapy and visual cueing to improve health and behaviour in Parkinson’s disease Investments > €500k Netherlands Parkinson’s disease & PD-related disorders 2016    

Function and activation mechanism of LRRK2 and the understanding of Parkinson’s disease Investments > €500k Netherlands Parkinson’s disease & PD-related disorders 2016    

Nutrition, the unrecognized determinant in Alzheimer?s disease (NUDAD) Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

The Heart-Brain Connection:the mssing link in the pathophysiology of vascular cognitive impairment Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

The effects of amyloid beta on synapses in the brain Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

ALS Kennisplatform fase 3: ‘Kennis delen voor betere zorg’ ALS Knowledge Platform Phase 3: Sharing Knowledge for Better Care Investments > €500k Netherlands Motor neurone diseases 2016    

Project MinE Investments > €500k Netherlands Motor neurone diseases 2016    

Project PSMA Investments > €500k Netherlands Spinal muscular atrophy (SMA) 2016    

Project Functionele analyse van het ALS interactoom Project Functional analysis of the ALS interactome Investments > €500k Netherlands Motor neurone diseases 2016    

Project Informal Caregivers Investments > €500k Netherlands Motor neurone diseases 2016    

Project TOTALS Investments > €500k Netherlands Motor neurone diseases 2016    

Project ALS Biobank en Database Investments > €500k Netherlands Motor neurone diseases 2016    

Project Beyond MinE-NL Investments > €500k Netherlands Motor neurone diseases 2016    

Project MRI onderzoek Investments > €500k Netherlands Motor neurone diseases 2016    

Maastricht Aging Study Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

Imaging the Retina for Early Alzheimer Diagnosis (I-READ) Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

Effects and costs of a day centre care program, designed for people with dementia – a 24 month controlled study (ECOD) Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Knowledge-based person centered activity for people with dementia living at home Investments > €500k Norway Alzheimer’s disease & other dementias 2016    

Effects on quality of life and family caregiving experiences by the Namaste Care Family program for advanced dementia Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

Hospital At Home care program for patients with dementia and an acute medical crisis Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

GRIP on neuropsychiatric symptoms in young-onset dementia: The BEYOND-II study Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

Identifying best practices in care trajectories of communitydwelling persons with dementia. A comparison of care trajectories, quality indicators and costs extracted from routine care registrations and health insurance data Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016  …

Bringing palliative care for dementia patients into agreement with their wishes and needs: development and evaluation of Decidem Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

CODE Z: Continuïteit van zorg bij Opname van mensen met Dementie in het Ziekenhuis (Continuity of care during and after unplanned hospital admissions of home-dwelling patients with dementia) Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

Adaptive Implementation and Validation of the positively evaluated Meeting Centers Support Programme for people with dementia and their carers in Europe (Meetingdem) Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

NurseSMS – A joint research program on Nurses’ Self-Management Support in people facing progressive incurable diseases Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

End-of-life care in institutionalized people with Young Onset Dementia (YOD): the Care4Youngdem-study Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

Imaging Dementia: Brain Matters Investments > €500k Netherlands Alzheimer’s disease & other dementias 2016    

The INVEST study (Infusion VErsus STimulation), a cost-effectiveness analysis of the treatment of advanced Parkinson’s disease comparing Continuous Levodopa Infusion to the traditional standard treatment Deep Brain Stimulation Investments > €500k Netherlands Parkinson’s disease & PD-related disorders 2016    

Bewegen met Parkinson: de Park-in-Shape studie Moving with Parkinson’s: the Park-in-Shape study Investments > €500k Netherlands Parkinson’s disease & PD-related disorders 2016    

CHolinEsterase inhibitors to slow progression of Visual hALlucinations in Parkinson’s disease: a multi-center placebo-controlled trial(CHEVAL) Investments > €500k Netherlands Parkinson’s disease & PD-related disorders 2016